Ziprasidone 20 MG Oral Capsule — RxCUI 314286
RxNorm drug concept · Semantic clinical drug
RxCUI 314286
Semantic clinical drug · SCD
● Current RxNorm concept 61 FDA products
107 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI314286
Official nameZiprasidone 20 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asziprasidone (as ziprasidone HCl monohydrate) 20 MG Oral Capsule; ziprasidone HCl 20 MG Oral Capsule
FDA products mapped61
Package NDCs mapped107
Reported Medicaid activity (SDUD)435,550 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ziprasidone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Geodon injection is designed to quickly calm severe agitation in adults who have schizophrenia. It's given as a shot into the muscle — not through an IV — when someone needs fast r...
- What is this injection actually for? My doctor said I might need it for agitation.
- The injection works relatively quickly because it goes directly into muscle tissue. Your care team can repeat doses every two to four hours if needed, up to a daily limit they set....
- How soon does it work, and how long will I be getting the shots?
🕸️ Concept Web — How Ziprasidone 20 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ziprasidone 20 MG Oral Capsule
RxCUI 314286 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ziprasidone
115698IN
-
Ziprasidone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Geodon
285064BN
-
Geodon
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ziprasidone Oral Capsule
374649SCDF -
Ziprasidone Oral Product
1156249SCDG -
Ziprasidone Pill
1156250SCDG -
Ziprasidone Oral Capsule [Geodon]
366540SBDF -
Geodon Oral Product
1170505SBDG -
Geodon Pill
1170506SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Ziprasidone Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ziprasidone 20 MG
330414SCDC -
Ziprasidone 20 MG Oral Capsule [Geodon]
285127SBD -
Ziprasidone 20 MG [Geodon]
575092SBDC
-
Ziprasidone 20 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ziprasidone 20 MG
SCDC · 330414 -
Ziprasidone Oral Capsule
SCDF · 374649 -
Ziprasidone Oral Product
SCDG · 1156249 -
Ziprasidone Pill
SCDG · 1156250
Brand-Name Concepts
-
Ziprasidone 20 MG Oral Capsule [Geodon]
SBD · 285127 -
Ziprasidone 20 MG [Geodon]
SBDC · 575092 -
Ziprasidone Oral Capsule [Geodon]
SBDF · 366540 -
Geodon Oral Product
SBDG · 1170505 -
Geodon Pill
SBDG · 1170506 -
Geodon
BN · 285064
📦 FDA Products & Package NDCs
61 products · 107 package NDCs
107 package NDCs map to RxCUI 314286 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68001-0453-06 | 60 CAPSULE in 1 BOTTLE (68001-453-06) | Ziprasidone Hydrochloride | BluePoint Laboratories | 2020-08-31 |
| 68071-3418-09 | 90 CAPSULE in 1 BOTTLE (68071-3418-9) | ziprasidone hydrochloride | NuCare Pharmaceuticals,Inc. | 2023-05-26 |
| 68084-0103-09 | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-103-09) / 1 CAPS... | Ziprasidone Hydrochloride | American Health Packaging | 2014-12-16 |
| 68084-0104-09 | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-104-09) / 1 CAPS... | Ziprasidone Hydrochloride | American Health Packaging | 2014-12-17 |
| 68084-0105-09 | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-105-09) / 1 CAPS... | Ziprasidone Hydrochloride | American Health Packaging | 2014-12-16 |
| 68084-0106-09 | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-106-09) / 1 CAPS... | Ziprasidone Hydrochloride | American Health Packaging | 2014-12-16 |
| 70518-1835-00 | 30 CAPSULE in 1 BLISTER PACK (70518-1835-0) | ziprasidone hydrochloride | REMEDYREPACK INC. | 2019-01-30 |
Observed labelers:
Dr. Reddy's Laboratories Limited (28) ·
Aurobindo Pharma Limited (12) ·
Macleods Pharmaceuticals Limited (12) ·
Major Pharmaceuticals (8) ·
ROERIG (7) ·
Proficient Rx LP (6)
· +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3486 | Ziprasidone mesylate | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.